The register
Every tracked technology, its claimed and verified readiness, and the gap between them. Free to read — how these scores are made.
First recorded –
showing 60 of 189 entries
| First recorded | Technology | Discipline | Claimed | Verified | 0 ─────────── 100 | Gap |
|---|---|---|---|---|---|---|
| 2026-09-28 | Leica Autiva spatial phenotyping platform | Medical Imaging & Diagnostics | 85 | 85 | 0 | |
| 2026-09-28 | LC-1 large-cargo-optimized lipid nanoparticles for genome editing | Synthetic Biology & Gene Editing | 40 | 40 | 0 | |
| 2026-09-25 | Supramolecular artificial-ion-channel OECTs | Bioelectronics & Electroceuticals | 40 | 40 | 0 | |
| 2026-09-15 | Amprion SAAmplify-αSYN Plus (CSF)Review incomplete | Medical Imaging & Diagnostics | 90 | 86 | +4 | |
| 2026-09-14 | BEXLUTRY (lutetium Lu 177 dotatate)Review incomplete | Drug Discovery & Development | 95 | 47 | +48 | |
| 2026-09-17 | Charles River Rapid Cell Banking with NGSReview incomplete | Drug Discovery & Development | 85 | 63 | +22 | |
| 2026-09-17 | FAYUVI (rebisufligene etisparvovec-hopf)Review incomplete | Synthetic Biology & Gene Editing | 90 | 80 | +10 | |
| 2026-09-11 | Isembyld (apitegromab) | Drug Discovery & Development | 55 | 55 | 0 | |
| 2022-12-10 | Arlo-cel (BMS GPRC5D-Directed CAR-T)Review incomplete | Vaccines & Immunotherapy | 60 | 51 | +9 | |
| 2026-09-03 | Zanvastro (Ionis Antisense Therapy) | Drug Discovery & Development | 55 | 55 | 0 | |
| 2026-09-03 | SimpleDesign (Apple)Review incomplete | Protein Design & Computational Biology | 30 | 23 | +7 | |
| 2026-08-28 | MIMRYLO (rusfertide)Review incomplete | Drug Discovery & Development | 100 | 89 | +11 | |
| 2026-08-27 | Lisraya (brepocitinib)Review incomplete | Drug Discovery & Development | 55 | 55 | 0 | |
| 2026-08-26 | Rasonque (daraxonrasib)Review incomplete | Drug Discovery & Development | 100 | 85 | +15 | |
| 2023-09-19 | AlphaMissense | Genomics & Multi-omics Sequencing | 55 | 45 | +10 | |
| 2022-09 | Illumina NovaSeq X / X PlusReview incomplete | Genomics & Multi-omics Sequencing | 92 | 80 | +12 | |
| 2023-07-06 | Leqembi (Lecanemab) Traditional FDA ApprovalReview incomplete | Drug Discovery & Development | 100 | 93 | +7 | |
| 2026-03-23 | Aperio iQC + Aperio GT Elite Scanner (Leica Biosystems)Review incomplete | Medical Imaging & Diagnostics | 90 | 78 | +12 | |
| 2016-05-05 | TAUKLARIFY (Florquinitau F 18)Review incomplete | Medical Imaging & Diagnostics | 90 | 81 | +9 | |
| 2025-05-11 | UNCOVERseq (IDT off-target CRISPR nomination method)Review incomplete | Synthetic Biology & Gene Editing | 85 | 74 | +11 | |
| 2026-07-31 | Samsung Galaxy Buds FDA Hearing Aid ClearanceReview incomplete | Wearables & Human Augmentation | 80 | 63 | +17 | |
| 2012-11 | Zenbexus (iberdomide) — first CELMoD therapyReview incomplete | Drug Discovery & Development | 55 | 55 | 0 | |
| 2026-08-11 | Skylark Bio SKY-GJB2 Gene TherapyReview incomplete | Synthetic Biology & Gene Editing | 20 | 10 | +10 | |
| 2026-08-09 | StairMed Endovascular Neck-Vein BCIReview incomplete | Brain-Computer Interfaces | 15 | 5 | +10 | |
| 2026-08-05 | Can f 1 Knockout Dogs (Kindred Companion Sciences)Review incomplete | Synthetic Biology & Gene Editing | 25 | 20 | +5 | |
| 2026-08-05 | DCAF11 Glutathionylation-Activated Molecular Glue Discovery PlatformReview incomplete | Drug Discovery & Development | 35 | 28 | +7 | |
| 2021-07-09 | mFLUSIVA (Moderna mRNA-1010) | Vaccines & Immunotherapy | 55 | 55 | 0 | |
| 2025-09-21 | Q100 Project — T2T Diploid Genome Benchmark | Genomics & Multi-omics Sequencing | 55 | 35 | +20 | |
| 2026-08-06 | Tudriqev (vusolimogene oderparepvec) + NivolumabReview incomplete | Vaccines & Immunotherapy | 55 | 45 | +10 | |
| 2026-08-04 | Moderna mRNA-1469 (Bundibugyo Ebola Vaccine, Phase 1)Review incomplete | Vaccines & Immunotherapy | 15 | 13 | +2 | |
| 2026-07-22 | Orzeyful (oveporexton, TAK-861)Review incomplete | Drug Discovery & Development | 60 | 55 | +5 | |
| 2025-01-20 | UC Irvine / GEG Tech mRNA-Delivered Rpe65 Base EditorReview incomplete | Synthetic Biology & Gene Editing | 20 | 16 | +4 | |
| 2024-02-14 | Latigo LTG-001 (Nav1.8 Inhibitor) Phase 2b NEJM ReadoutReview incomplete | Drug Discovery & Development | 45 | 40 | +5 | |
| 2026-07-29 | Viatris Gwyn Lo Low-Dose Weekly Contraceptive PatchReview incomplete | Drug Discovery & Development | 58 | 46 | +12 | |
| 2024-11-22 | Neuvotion NeuStim NN-01Review incomplete | Bioelectronics & Electroceuticals | 70 | 30 | +40 | |
| 2024-05-08 | AlphaFold 3 | Protein Design & Computational Biology | 70 | 55 | +15 | |
| 2024-09-25 | Chai-1Review incomplete | Drug Discovery & Development | 55 | 45 | +10 | |
| 2024-06-25 | ESM3 | Protein Design & Computational Biology | 55 | 35 | +20 | |
| 2024-07-02 | Kisunla (donanemab)Review incomplete | Drug Discovery & Development | 70 | 57 | +13 | |
| 2026-07-22 | GSK Jideytro (zidesamtinib)Review incomplete | Drug Discovery & Development | 55 | 55 | 0 | |
| 2026-07-22 | Ivonescimab (Summit/Akeso) — Western HARMONi OS DataReview incomplete | Drug Discovery & Development | 70 | 65 | +5 | |
| 2026-07-22 | Plozasiran (REDEMPLO) -- RNAi Therapy for Severe HypertriglyceridemiaReview incomplete | Drug Discovery & Development | 72 | 72 | 0 | |
| 2026-07-22 | Science Corporation PRIMA Retinal ImplantReview incomplete | Bioelectronics & Electroceuticals | 85 | 69 | +16 | |
| 2026-04-08 | Patient-Derived Brain Organoid Platform for Alzheimer's Drug-Response Prediction (Johns Hopkins)Review incomplete | Drug Discovery & Development | 25 | 23 | +2 | |
| 2026-07-20 | Dyne Therapeutics Zeleciment Rostudirsen (z-Rostudirsen / DYNE-251) — FDA-Accepted Exon-51-Skipping DMD TherapyReview incomplete | Drug Discovery & Development | 80 | 73 | +7 | |
| 2026-07-13 | Neuracle NEO (China's First Commercial BCI Implant)Review incomplete | Brain-Computer Interfaces | 68 | 54 | +14 | |
| 2026-07-16 | Lipfendra (enlicitide)Review incomplete | Drug Discovery & Development | 92 | 78 | +14 | |
| 2026-07-14 | Gedatolisib (Revtorpyk) | Drug Discovery & Development | 55 | 55 | 0 | |
| 2026-07-07 | Atacicept (Trutakna) | Vaccines & Immunotherapy | 65 | 55 | +10 | |
| 2025-06-23 | Corxel CX11 (oral GLP-1)Review incomplete | Drug Discovery & Development | 42 | 29 | +13 | |
| 2022-05-13 | Zepbound (tirzepatide) | Drug Discovery & Development | 75 | 65 | +10 | |
| 2024-03-05 | Dexcom Stelo Glucose Biosensor SystemReview incomplete | Wearables & Human Augmentation | 82 | 76 | +6 | |
| 2023 | AgriPass RHIC robotic weederReview incomplete | AgriTech & Precision Agriculture | 50 | 42 | +8 | |
| 2026-06-25 | Aidoc First ReadReview incomplete | Medical Imaging & Diagnostics | 35 | 10 | +25 | |
| 2024-10-02 | FlyWire Codex Whole-Brain Connectome PlatformReview incomplete | Neuroscience & Neurotechnology | 80 | 67 | +13 | |
| 2026-01-22 | John Deere See & Spray Gen 2 + See & ScoutReview incomplete | AgriTech & Precision Agriculture | 90 | 79 | +11 | |
| 2025-03-03 | Microsoft Dragon CopilotReview incomplete | Digital Health & Medical AI | 88 | 71 | +17 | |
| 2022-02-22 | Onego Bio Bioalbumen (animal-free ovalbumin)Review incomplete | Food Tech & Alternative Proteins | 72 | 67 | +5 | |
| 2024-02-05 | Singular Genomics G4X Spatial SequencerReview incomplete | Genomics & Multi-omics Sequencing | 85 | 62 | +23 | |
| 2026-02-24 | Vivici Vivitein LF (precision-fermented lactoferrin)Review incomplete | Food Tech & Alternative Proteins | 63 | 57 | +6 |
No technologies match those filters. Widen the domain or discipline, or clear the search to see all 1,452 entries.
isn't on the register yet.
File it for verification — new entries are researched, sourced, and scored before they appear. Leave an email and we'll tell you when its reading is live.